Target intelligence / Profile preview

ZNF706 neighboring transcript 1 (ZNNT1)

Target
ZNNT1
Molecular classification
long noncoding RNA (lncRNA)
01

Overview

ZNF706 neighboring transcript 1 (ZNNT1) is a long noncoding RNA (lncRNA) gene located near the ZNF706 gene on chromosome 8. ZNNT1 is involved in regulating autophagy, cell proliferation, and tumorigenesis in a context-dependent manner. In uveal melanoma, ZNNT1 acts as a tumor suppressor by promoting autophagy and inhibiting tumor cell migration and growth, especially downstream of mTOR inhibition[1]. In colon cancer, ZNNT1 functions as an oncogenic lncRNA, promoting tumorigenicity by destabilizing p53 via interaction with SART3, influencing the protein degradation pathway[4]. ZNNT1's role is under active investigation, with its expression and function linked to key oncogenic and tumor suppressive pathways. It is a potential molecular target in cancer therapy and a candidate biomarker for cancer diagnosis and prognosis[1][4][5].

Other names
AP003469.4ZNNT1n341569lnc-ZNF706-1-1_dup1
02

Mechanism of action

induction of autophagy via upregulation of ATG12/ATG5 and conversion of LC3-I to LC3-II. Promotion of p53 protein ubiquitination and proteasome-mediated degradation (reducing p53 stability in colon cancer cells). Interaction with SART3, inhibiting the SART3-USP15 complex-mediated p53 stabilization.

03

Biological functions

regulation of autophagy (promotes autophagy by upregulating ATG12/ATG5)regulation of cell proliferation and tumorigenesisregulation of cell death and survival (through autophagy and interaction with p53 pathway)regulation of gene expression at the transcriptional level (predominantly nuclear localization)
04

Disease associations

cancer (tumor suppressor in uveal melanoma; oncogene in colon cancer)potential involvement in other cancers (suggested by pathway analysis)
05

Safety considerations

As a therapeutic target, potential concerns include context-dependent effects: ZNNT1 acts as a tumor suppressor in uveal melanoma but as an oncogene in colon cancer, indicating tissue-specific functional rolesPossible off-target effects when modulating ZNNT1 in non-target tissues
06

Interacting drugs

rapamycin (MTORC1 inhibitor; ZNNT1 expression induced in the presence of rapamycin)

2 more in the full profile.

07

Biomarkers

ZNNT1 expression levels (potential biomarker for uveal melanoma and colon adenocarcinomas)autophagy markers (e.g., LC3-II, p62/SQSTM1 degradation, ATG12 upregulation in the context of ZNNT1)

Beyond the preview

Go deeper on ZNF706 neighboring transcript 1 (ZNNT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF706 neighboring transcript 1 (ZNNT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call